PMID- 35616198 OWN - NLM STAT- MEDLINE DCOM- 20220527 LR - 20220915 IS - 1872-2059 (Electronic) IS - 1000-8713 (Print) IS - 1000-8713 (Linking) VI - 40 IP - 6 DP - 2022 Jun TI - [Ultra-high performance liquid chromatography-orbitrap high-resolution mass spectrometry for rapid screening and identification of 32 illegally added drugs in slimming and anti-impotence health foods]. PG - 531-540 LID - 10.3724/SP.J.1123.2021.12009 [doi] AB - A novel method based on ultra-high performance liquid chromatography-orbitrap high-resolution mass spectrometry (UHPLC-Orbitrap HRMS) was developed for the rapid screening and confirmation of 32 illegally added drugs in slimming and anti-impotence health foods. In addition, the key points of the database establishment and application are summarized. This research focused on the derivatives of illegally added drugs. An HRMS database was established by comparing the response intensity of each compound in the positive and negative modes. The experimental conditions such as the type of extraction solvent and chromatographic column temperature were explored in detail. The analytes were separated on a Hypersil gold vanquish column (100 mmx2.1 mm, 1.9 mum) by gradient elution with acetonitrile/water (containing 0.1%(v/v) formic acid) as the mobile phase at a flow rate of 0.3 mL/min. Positive and negative ion full scanning/data-dependent secondary scanning mode was used to collect the 32 target compounds within 17 min, and TraceFinder software was used to screen the fragment ions. All the 32 compounds could be well separated within 17 min. The measured and theoretical values of the exact mass of the 32 compounds in the two matrix-spiked solutions were within an error of 5x10(-6), and the MS(2) fragment ions were within an error of 1x10(-5). All the compounds showed an excellent linear relationship, with correlation coefficients (r(2)) above 0.99. Except dapoxetine, hydroxythiohomo sildenafil, thiohomo sildenafil, thiosildenafil, desmethyl thiosildenafil, the recoveries ranged from 50.5% to 84.5% in the solid matrix, with the relative standard deviations (RSDs) ranging from 1.2% to 13%. The recoveries were 60.4% to 109.3% in the liquid matrix, with the RSDs ranging from 0.77% to 8.2%. The matrix effect (ME) values of the 32 compounds ranged from 0.61 to 0.95 in the solid matrix and from 0.73 to 1.09 in the liquid matrix. Thiohomo sildenafil, desmethyl thiosildenafil, and chlorpretadalafil exhibited strong matrix inhibitory effects in the solid matrix. Therefore, solid and liquid negative matrix extracts were used to prepare a series of mixed standard solutions in order to reduce the ME values. The limits of detection (LODs) were 0.02 mg/kg for the 32 drugs in the liquid sample and 0.02 mg/kg for 29 compounds in the solid sample; the LODs for chlorothalidone, udenafil, and desmethyl thiosildenafil in the solid sample were 0.04 mg/kg. When the retention time in the self-built database matches the sample collection method, it should be used as one of the screening conditions. As for the selection of the matching mode, if the identify mode is selected, the retention time is a necessary condition for compound confirmation. When the retention time does not meet the requirements, subsequent screening of the fragment ions and isotope abundance ratios will not be performed. If the confirm mode is selected, the retention time is the optional condition for compound confirmation. When the retention time does not meet these requirements, subsequent matching of other conditions such as fragment ions and isotope information is required. Isotope information is very important in HRMS and is an effective supplement to the first-order extracted mass. Therefore, its use is recommended, but the isotope abundance ratio will be even lower when the target content is very low in the complex matrix, which may affect isotope matching. In addition, if the fragment ions are not detected in the screening results of the TraceFinder software but can be extracted in the data browser, their intensity threshold in the screening conditions can be further reduced to find the corresponding fragment ions. One positive sample was detected among 48 healthy food samples, with a detection rate of 2.08%. This method has the advantages of simple operation and high accuracy. It can be used for the rapid screening and confirmation of 32 illegally added drugs in slimming and anti-impotence health foods. FAU - Xu, Hongbin AU - Xu H AD - Shanghai Institute of Quality Inspection and Technical Research, State Key Laboratory of Milk and Dairy Products Detection and Monitoring Technology for State Market Regulation, Shanghai 200233, China. FAU - Zhang, Shenping AU - Zhang S AD - Shanghai Institute of Quality Inspection and Technical Research, State Key Laboratory of Milk and Dairy Products Detection and Monitoring Technology for State Market Regulation, Shanghai 200233, China. FAU - DU, Ruyun AU - DU R AD - Shanghai Institute of Quality Inspection and Technical Research, State Key Laboratory of Milk and Dairy Products Detection and Monitoring Technology for State Market Regulation, Shanghai 200233, China. FAU - Zhou, Jing AU - Zhou J AD - Shanghai Institute of Quality Inspection and Technical Research, State Key Laboratory of Milk and Dairy Products Detection and Monitoring Technology for State Market Regulation, Shanghai 200233, China. FAU - Weng, Shiyu AU - Weng S AD - Shanghai Institute of Quality Inspection and Technical Research, State Key Laboratory of Milk and Dairy Products Detection and Monitoring Technology for State Market Regulation, Shanghai 200233, China. LA - chi PT - Journal Article PL - China TA - Se Pu JT - Se pu = Chinese journal of chromatography JID - 9424804 RN - BW9B0ZE037 (Sildenafil Citrate) SB - IM MH - Chromatography, High Pressure Liquid MH - Limit of Detection MH - Sildenafil Citrate MH - *Tandem Mass Spectrometry PMC - PMC9404125 OTO - NOTNLM OT - health foods OT - high-resolution mass spectrometry (HRMS) OT - illegally added drugs OT - rapid screening OT - ultra-high performance liquid chromatography (UHPLC) EDAT- 2022/05/27 06:00 MHDA- 2022/05/28 06:00 PMCR- 2022/06/08 CRDT- 2022/05/26 06:32 PHST- 2022/05/26 06:32 [entrez] PHST- 2022/05/27 06:00 [pubmed] PHST- 2022/05/28 06:00 [medline] PHST- 2022/06/08 00:00 [pmc-release] AID - 10.3724/SP.J.1123.2021.12009 [doi] PST - ppublish SO - Se Pu. 2022 Jun;40(6):531-540. doi: 10.3724/SP.J.1123.2021.12009.